Decreased expression of catalase mRNA in thyroid anaplastic carcinoma

Japanese Journal of Clinical Oncology

Volumn 33, Issue 1, 2003, Pages 6-9

  Hasegawa, Yukiko ^a   Takano, Toru ^a   Miyauchi, Akira ^b   Matsuzuka, Fumio ^b   Yoshida, Hiroshi ^b   Kuma, Kanji ^b   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Anaplastic carcinoma; Catalase; mRNA; Superoxide dismutase; Thyroid

Indexed keywords

CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; OXYGEN RADICAL; COPPER; SUPEROXIDE DISMUTASE; ZINC;

ANAPLASTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OXIDATIVE STRESS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID GLAND; THYROID TUMOR; TUMOR DIFFERENTIATION; ADENOMA; BIOSYNTHESIS; CARCINOMA; ENZYMOLOGY; GENETICS; METABOLISM; PAPILLARY CARCINOMA;

ADENOMA; CARCINOMA; CARCINOMA, PAPILLARY; CATALASE; COPPER; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE; THYROID NEOPLASMS; ZINC;

EID: 0037268727     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg009     Document Type: Article

References (26)

1. Hasegawa Y, Takano T, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K, et al. Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma. Cancer Lett 2002;182:69-74.
2. Takano T, Hasegawa Y, Matsuzuka F, Miyauchi A, Yoshida H, Higashiyama T, et al. Gene expression profiles in thyroid carcinomas. Br J Cancer 2000;83:1495-502.
3. Durak I, Bayram F, Kavutcu M, Canbolat O, Ozturk HS. Impaired enzymatic antioxidant defense mechanism in cancerous human thyroid tissues. J Endocrinol Invest 1996;19:312-5.
4. Lauer C, Volkl A, Riedl S, Fahimi HD, Beier K. Impairment of peroxisomal biogenesis in human colon carcinoma. Carcinogenesis 1999;20: 985-9.
5. Wei LK. The clinical and laboratory studies of superoxide dismutase activities in the human whole blood with early gastric cancer. Free Rad Res Commun 1991;12:759-60.
6. Ishikawa M, Yaginuma Y, Hayashi H, Shimizu T, Endo Y, Taniguchi N. Reactivity of a monoclonal antibody to manganese superoxide dismutase with human ovarian carcinoma. Cancer Res 1990;50:2538-42.
7. Kawamura N, Suzuki K, Ishikawa M, Iizuka S, Miyake M, Mino M, et al. High level of Mn-superoxide dismutase in serum of patients with neuroblastoma and in human neuroblastoma cell lines. Free Rad Biol Med 1992; 12:281-6.
8. Corrocher R, Casaril M, Bellisola G, Nicoli N, Guidi GC, De Sandre G. Severe impairment of antioxidant system in human hepatoma. Cancer 1986;15:1658-62.
9. Singh SV, Brunnert SR, Roberts B, Krishan A. Differential expression of glutathione S-transferase, glutathione peroxidase and glutathione reductase in normal and malignant human breast tissues. Cancer Lett 1990;51:43-8.
10. Elisei R, Pinchera A, Romei C, Gryczynska M, Pohl V, Maenhaut C, et al. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase and calcitonin messenger ribonucleic acids in thyroid carcinomas: Evidence of TSH-R gene transcript in medullary histotype. J Clin Endocrinol Metab 1994;78:867-71.
11. Takano T, Miyauchi A, Yokozawa T, Matsuzuka F, Maeda I, Kuma K, et al. Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Res 1999;59:4542-5.
12. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
13. Bell GI, Najarian RC, Mullenbach GT, Hallewell RA. cDNA sequence coding for human kidney catalase. Nucleic Acids Res 1986;14:5561-2.
14. Hallewell RA, Masiarz FR, Najarian RC, Puma JP, Quiroga MR, Randolph A, et al. Human Cu/Zn superoxide dismutase cDNA: Isolation of clones synthesising high levels of active or inactive enzyme from an expression library. Nucleic Acids Res 1985;13:2017-34.
15. Heckl K. Isolation of cDNAs encoding human manganese superoxide dismutase. Nucleic Acids Res 1988;16:6224.
16. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984;12:1687-96.
17. 2-generating machinery. Biochemistry 1991;30:4880-6.
18. Bannister JV, Bannister W, Rotilio G. Aspects of the structure, function and applications of superoxide dismutase. Crit Rev Biochem 1987;22: 111-80.
19. Hassan HM. Biosynthesis and regulation of superoxide dismutases. Free Rad Biol Med 1988;5:377-85.
20. Touati D. Molecular genetics of superoxide dismutases. Free Rad Biol Med 1998;5:393-402.
21. Litwin JA, Beier K, Volkl A, Hofmann WJ, Fahimi HD. Immunocytochemical investigation of catalase and peroxisomal lipid β-oxidation enzymes in human hepatocellular tumors and liver cirrhosis. Virchows Arch 1999;435:486-95.
22. Toh Y, Kuninaka S, Mori M, Oshiro T, Ikeda Y, Nakashima H, et al. Reduced expression of manganese superoxide dismutase mRNA may correlate with invasiveness in esophageal carcinoma. Oncology 2000;59: 223-8.
23. Saito H, Kuroki T, Nose K. Decrease in CuZn-superoxide dismutase mRNA level during differentiation of human monocytic and promyelotic leukemia cells. FEBS Lett 1989;249:253-6.
24. Sadani GR, Nadkarni GD. Role of tissue antioxidant defence in thyroid cancers. Cancer Lett 1996;109:231-5.
25. Mano T, Shinohara R, Iwase K, Kotake M, Hamada M, Uchimura K, et al. Changes in free radical scavengers and lipid peroxide in thyroid glands of various thyroid disorders. Horm Metab Res 1997;29:351-4.
26. Nishida S, Akai F, Iwasaki H, Hosokawa K, Kusunoki T, Suzuki K, et al. Manganese superoxide dismutase content and localization in human thyroid tumors. J Pathol 1993;169:341-5.